Treatment of patients with the hypereosinophilic syndrome with mepolizumab by Rothenberg Marc E, Klion Amy D, Roufosse Florence E, Kahn Jean Emmanuel, Weller Peter F, Simon Hans-Uwe, Schwartz Lawrence B, Rosenwasser Lanny J, Ring Johannes, Griffin Elaine F, Haig Ann E, Frewer Paul I H, Parkin Jacqueline M, Gleich Gerald J, Mepolizumab HES Study Group in The New England journal of medicine (2008).

[PMID: 18344568] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.